Borrowed from : The National MS Society
Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system is directed against the central nervous system (CNS). The CNS is made up of the brain, spinal cord and optic nerves.
Within the CNS, the immune system causes inflammation that damages myelin — the fatty substance that surrounds and insulates the nerve fibers — as well as the nerve fibers themselves, and the specialized cells that make myelin.
- When myelin or nerve fibers are damaged or destroyed in MS, messages within the CNS are altered or stopped completely.
- Damage to areas of the CNS may produce a variety of neurological symptoms that will vary among people with MS in type and severity
- The damaged areas develop scar tissue which gives the disease its name – multiple areas of scarring or multiple sclerosis.
- The cause of MS is not known, but it is believed to involve genetic susceptibility, abnormalities in the immune system and environmental factors that combine to trigger the disease.
- People with MS typically experience one of four disease courses. There are over a dozen treatments to help modify the MS disease process.
Myelin – the protective coating around nerve fibers in the central nervous system – is a primary target of the immune attack in MS.
THE TYPES OF MULTIPLE SCLEROSIS
Clinically Isolated Syndrome (CIS)
CIS is a first episode of neurologic symptoms caused by inflammation and demyelination in the central nervous system. The episode, which by definition must last for at least 24 hours, is characteristic of multiple sclerosis but does not yet meet the criteria for a diagnosis of MSbecause people who experience a CIS may or may not go on to develop MS.
When CIS is accompanied by lesions on a brain MRI (magnetic resonance imaging) that are similar to those seen in MS, the person has a high likelihood of a second episode of neurologic symptoms and diagnosis of relapsing-remitting MS. When CIS is not accompanied by MS-like lesions on a brain MRI, the person has a much lower likelihood of developing MS.
The 2017 diagnostic criteria for MS make it possible to diagnose MS in a person with CIS who also has specific findings on brain MRI that provide evidence of an earlier episode of damage in a different location and indicate active inflammation in a region other than the one causing the current symptoms. As MRI technology improves, the diagnosis of MS will be made more quickly and easily. In the meantime, individuals with CIS who are considered at high risk for developing MS may now be treated with a disease-modifying therapy that has been approved by the U.S. Food and Drug Administration (FDA) for that purpose. Early treatment of CIS has been shown to delay onset of MS.
Relapsing-remitting MS (RRMS)
RRMS – the most common disease course – is characterized by clearly defined attacks of new or increasing neurologic symptoms. These attacks – also called relapses or exacerbations – are followed by periods of partial or complete recovery (remissions). During remissions, all symptoms may disappear, or some symptoms may continue and become permanent. However, there is no apparent progression of the disease during the periods of remission. At different points in time, RRMS can be further characterized as either active (with relapses and/or evidence of new MRI activity) or not active, as well as worsening (a confirmed increase in disability over a specified period of time following a relapse) or not worsening.
Approximately 85 percent of people with MS are initially diagnosed with RRMS.
This graphic shows the kinds of disease activity that can occur in RRMS over time; however each person’s experience with RRMS will be unique. Following a relapse, the new symptoms may disappear without causing any increase in level of disability, or the new symptoms may partially disappear, resulting in an increase in disability. New lesions on MRI, as shown by the arrows, often occur as part of a relapse. However, new MRI lesions indicating MS activity may also occur without symptoms of which the person is aware.
Secondary progressive MS (SPMS)
This graphic shows the kinds of disease activity that can occur in SPMS over time; however each person’s experience with SPMS will be unique. SPMS follows after relapsing-remitting MS. Disability gradually increases over time, with or without evidence of disease activity (relapses or changes on MRI). In SPMS, occasional relapses may occur, as well as periods of stability.
Primary progressive MS (PPMS)
PPMS is characterized by worsening neurologic function (accumulation of disability) from the onset of symptoms, without early relapses or remissions. PPMS can be further characterized at different points in time as either active (with an occasional relapse and/or evidence of new MRI activity) or not active, as well as with progression (evidence of disease worsening on an objective measure of change over time, with or without relapse or new MRI activity) or without progression.
Approximately 15 percent of people with MS are diagnosed with PPMS.
This graphic shows the kinds of disease activity that can occur in PPMS over time; however each person’s experience with PPMS will be unique. PPMS can have brief periods when the disease is stable, with or without a relapse or new MRI activity, as well as periods when increasing disability occurs with or without new relapses or lesions on MRI.
- Marburg’s Variant Multiple Sclerosis
- A variant of MS that needs to be understood. Click here for more information on this tragic from of the disease.